(b) Meta-analyses of insulin and cancer
| Study | Publish Year country (study Yrs) | Total number of studies | Total (n) | Insulin analyzed | Increased risk? | |
|---|---|---|---|---|---|---|
| Dejgaard et al. [83] Meta-analysis of randomized controlled Novo Nordisk trials Type I and Type II | 2009 Denmark | 21 | 8693 | Detemir NPH glargine | No (i) Glargine and detemir had similar risk |
Yes (i) NPH had more risk than detemir |
|
| ||||||
| Home et al. [84] Meta-analysis of randomized controlled Sanofi Aventis trials Type I and Type II | 2009 United Kingdom | 31 | 10,880 | Glargine | No | |